Fort Washington Investment Advisors Inc. OH Raises Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Fort Washington Investment Advisors Inc. OH lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 943,300 shares of the company’s stock after purchasing an additional 54,830 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Option Care Health were worth $21,885,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in OPCH. Envestnet Asset Management Inc. grew its stake in shares of Option Care Health by 2.8% in the second quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock worth $6,407,000 after acquiring an additional 6,283 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 6.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Intech Investment Management LLC acquired a new position in Option Care Health during the 2nd quarter worth $1,014,000. Bank of Montreal Can increased its holdings in Option Care Health by 2.9% during the 2nd quarter. Bank of Montreal Can now owns 51,667 shares of the company’s stock worth $1,461,000 after purchasing an additional 1,477 shares during the period. Finally, Squarepoint Ops LLC acquired a new stake in Option Care Health in the 2nd quarter valued at about $4,979,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Down 0.5 %

NASDAQ OPCH opened at $29.31 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The firm’s fifty day moving average is $23.96 and its two-hundred day moving average is $27.77. The firm has a market cap of $4.99 billion, a PE ratio of 24.63, a P/E/G ratio of 2.09 and a beta of 1.31.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on OPCH. Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus price target of $29.86.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.